Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience.
Alkhaldi H, Goloubeva O, Rapoport AP, Dahiya S, Pang Y, Ali MM, Hardy NM, Mohindra P, Bukhari A, Lutfi F, Sanchez-Petitto G, Molitoris J, Samanta S, Li X, Toth T, Landau M, Hodges S, Nishioka J, Ruehle K, Ridge L, Gahres N, Kocoglu MH, Atanackovic D, Malinou JN, Yared JA. Alkhaldi H, et al. Among authors: rapoport ap. Transplant Proc. 2023 Jan-Feb;55(1):214-224. doi: 10.1016/j.transproceed.2022.10.061. Epub 2023 Jan 11. Transplant Proc. 2023. PMID: 36635141
Chimeric antigen receptor T-cell therapy after allogeneic stem cell transplant for relapsed/refractory large B-cell lymphoma.
Lutfi F, Holtzman N, Siglin J, Bukhari A, Mustafa Ali M, Kim D, Sanchez-Petitto G, Gottlieb D, Ruehle K, Hutnick E, Gahres N, Hankey K, Lee S, Kocoglu M, Yared J, Hardy N, Rapoport A, Dahiya S. Lutfi F, et al. Br J Haematol. 2021 Jan;192(1):212-216. doi: 10.1111/bjh.17121. Epub 2020 Nov 10. Br J Haematol. 2021. PMID: 33169845 Free article. No abstract available.
Acute glomerulonephritis in a hematopoietic blood stem cell donor.
Chandra P, Dahiya S, Sanchez-Petitto G, Malik J, Bolanos J, Haririan A, Weir M, Drachenberg C, Rapoport A. Chandra P, et al. Clin Nephrol Case Stud. 2021 Jul 1;9:81-86. doi: 10.5414/CNCS110538. eCollection 2021. Clin Nephrol Case Stud. 2021. PMID: 34235045 Free PMC article.
Can Janus kinase inhibition improve ocular graft versus host disease?
Sajjan S, Tibbs E, Utz M, Rapoport AP, Yared J, Dahiya S, Cao X, Hardy N, Sunshine SB. Sajjan S, et al. Among authors: rapoport ap. Ocul Surf. 2023 Apr;28:27-29. doi: 10.1016/j.jtos.2023.01.001. Epub 2023 Jan 10. Ocul Surf. 2023. PMID: 36634844 Free PMC article. No abstract available.
Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD).
Kline K, Chen W, Kallen ME, Koka R, Omili D, Fan X, Iraguha T, Gebru E, Dishanthan N, Baker JM, Dietze KA, Yared JA, Hankey K, Dahiya S, Niederhaus SV, Dunleavy K, Hardy NM, Luetkens T, Rapoport AP, Atanackovic D. Kline K, et al. Among authors: rapoport ap. Hum Vaccin Immunother. 2023 Aug 1;19(2):2216116. doi: 10.1080/21645515.2023.2216116. Epub 2023 Jun 6. Hum Vaccin Immunother. 2023. PMID: 37278257 Free PMC article.
Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by 18F-FDG PET/CT Imaging Following CAR-T Therapy.
Lutfi F, Goloubeva O, Kowatli A, Gryaznov A, Kim DW, Dureja R, Margiotta P, Matsumoto LR, Bukhari A, Ahmed N, Mushtaq MU, Law JY, Lee ST, Kocoglu MH, Atanackovic D, Yared JA, Hardy NM, McGuirk JP, Rapoport AP, Chen W, Dahiya S. Lutfi F, et al. Among authors: rapoport ap. Clin Lymphoma Myeloma Leuk. 2023 Oct;23(10):757-763. doi: 10.1016/j.clml.2023.06.005. Epub 2023 Jun 19. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37453865 Free article.
Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells.
Kathari YK, Ahmad H, Kallen ME, Koka R, Omili D, Iraguha T, Clement J, Pham L, Khalid M, Fan X, Gebru E, Lesho P, Park E, Dishanthan N, Baker JM, Dietze KA, Hankey KG, Badros A, Yared JA, Dahiya S, Hardy NM, Kocoglu H, Luetkens T, Rapoport AP, Atanackovic D. Kathari YK, et al. Among authors: rapoport ap. Haematologica. 2024 Feb 1;109(2):682-688. doi: 10.3324/haematol.2023.283296. Haematologica. 2024. PMID: 37675514 Free PMC article. No abstract available.
A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell products.
Atanackovic D, Iraguha T, Omili D, Avila SV, Fan X, Kocoglu M, Gebru E, Baker JM, Dishanthan N, Dietze KA, Oluwafemi A, Hardy NM, Yared JA, Hankey K, Dahiya S, Rapoport AP, Luetkens T. Atanackovic D, et al. Among authors: rapoport ap. Cytotherapy. 2024 Apr;26(4):318-324. doi: 10.1016/j.jcyt.2024.01.006. Epub 2024 Feb 10. Cytotherapy. 2024. PMID: 38340107
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells.
Kline K, Luetkens T, Koka R, Kallen ME, Chen W, Ahmad H, Omili D, Iraguha T, Gebru E, Fan X, Miller A, Dishanthan N, Baker JM, Dietze KA, Hankey KG, Yared JA, Hardy NM, Rapoport AP, Dahiya S, Atanackovic D. Kline K, et al. Among authors: rapoport ap. Cancer Immunol Immunother. 2024 Feb 13;73(3):45. doi: 10.1007/s00262-023-03619-9. Cancer Immunol Immunother. 2024. PMID: 38349430 Free PMC article.
139 results